Dispensing Pharmacies Boosting Japan's Generic Market

Dispensing pharmacies and DPC hospitals to play major role in the market growth for Japan's generics market, says RNCOS.

Noida, India (prHWY.com) March 19, 2012 - Usually, generic drugs are as effective as their master drugs and are available to patients at a considerably low cost. As a result, generic drugs are increasingly being used across the world and the governments are also devising strategies to make them more accessible to society.

A new research report entitled, "Japan Generics Market Analysis", from RNCOS says that the NIH pharmacies and Diagnosis Procedure Combination (DPC)-based hospitals are playing a major role in promoting generics in Japan. NIH pharmacies have become valuable sources for promotion of generic drugs as they facilitate procedures including information sharing, quality provision, and stable supply. DPC-based hospitals are also growing through their effective promotion of generics. The Japanese generics market has shown positive developments over the past few years and is expected to grow at a CAGR of around 9% during 2012-2014.

The report spread over in 55 pages provides a comprehensive analysis on the prevalence of generics in Japan. The distribution of generic drugs in Japan is carried on through several channels, such as wholesalers, agents, direct sales, and consignments. In the past year, there have been several generic launches in the country. Further, it has been evaluated during the study that the key generic launches in Japan prevailed in the disease segments of neurological and behavioral disorders, anti-diabetics, and for circulatory disorders.

The report provides an in-depth research and rational analysis of the current status and expected position of the generics market in Japan. It covers the overall pharma market and provides a detailed analysis of the generics market in Japan. An analysis of the majority expenditures areas by disease segments and population age groups has been provided that facilitates a prudent analysis to the reader. The report further covers details of the penetration of generics and lay emphasis on the distribution channels involved in Japan. The analysis of the regulatory environment and government initiatives in the country also provide a holistic understanding to the industry.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM371.htm

Some of our Related Reports are:

- Generic Drug Market in Canada (http://www.rncos.com/Report/IM598.htm)
- Cancer Generics Market Analysis (http://www.rncos.com/Report/IM353.htm)
- Booming Generics Drug Market in India (http://www.rncos.com/Report/IM256.htm)
- UK Generics Market Analysis (http://www.rncos.com/Report/IM313.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: japan dpc hospitals

Categories: Health

Press Release Contact
RNCOS E-Services Pvt. Ltd.
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code